Xiaoxia Gu

846 total citations
29 papers, 663 citations indexed

About

Xiaoxia Gu is a scholar working on Molecular Biology, Cancer Research and Nephrology. According to data from OpenAlex, Xiaoxia Gu has authored 29 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Nephrology. Recurrent topics in Xiaoxia Gu's work include MicroRNA in disease regulation (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Dialysis and Renal Disease Management (3 papers). Xiaoxia Gu is often cited by papers focused on MicroRNA in disease regulation (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Dialysis and Renal Disease Management (3 papers). Xiaoxia Gu collaborates with scholars based in China, Hong Kong and United States. Xiaoxia Gu's co-authors include Hua Li, Mengzhu Zheng, Lixia Chen, Yirong Zhou, Canrong Wu, Qingzhe Zhang, Kaiyin Yang, Qifeng Liu, Lixia Yu and Yu Liu and has published in prestigious journals such as ACS Applied Materials & Interfaces, Environmental Pollution and Journal of Medicinal Chemistry.

In The Last Decade

Xiaoxia Gu

26 papers receiving 655 citations

Peers

Countries citing papers authored by Xiaoxia Gu

Since Specialization

Citations

This map shows the geographic impact of Xiaoxia Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxia Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxia Gu more than expected).

Fields of papers citing papers by Xiaoxia Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxia Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxia Gu. The network helps show where Xiaoxia Gu may publish in the future.

Co-authorship network of co-authors of Xiaoxia Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxia Gu. A scholar is included among the top collaborators of Xiaoxia Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxia Gu. Xiaoxia Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overview of host-directed antiviral targets for future research and drug development 2025 ·Acta Pharmaceutica Sinica B ·Xiaoxia Gu, Mengzhu Zheng, Ya Gao, Shuang Lin, Xiaotian Zhang, Chunmei Chen, Hucheng Zhu, Weiguang Sun, (unknown)	6
2	Remimazolam for preventing sevoflurane-induced emergence delirium after pediatric laparoscopic inguinal hernia repair: a placebo-controlled randomized clinical trial 2025 ·Jornal de Pediatria ·Yiwen Lu, (unknown), Yan Lü, Jingjing Wang, Ji‐Hun Mo, Zhiyuan Chen, (unknown), Kui Hu, (unknown), Xiaoxia Gu	0
3	Cydonia oblonga extract mediated biosynthesis of gold nanoparticles: Analysis of its anti-oral cancer and antioxidant properties 2024 ·Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy ·Xiaoxia Gu, (unknown), Lei Yang, Qinyi Wang, (unknown), (unknown), Attalla F. El‐kott, Ali G. Alkhathami, Kareem Morsy	5
4	Collective synthesis of aspulvinone and its analogues by vinylogous aldol condensation of substituted tetronic acids with aldehydes 2023 ·RSC Advances ·(unknown), Xiaoxia Gu, Yunpeng Zhao, Feng‐Qing Wang, Weiguang Sun, Changxing Qi, Lianghu Gu, Yonghui Zhang	1
5	Propofol inhibits myocardial injury induced by microvesicles derived from hypoxia-reoxygenated endothelial cells via lncCCT4-2/CCT4 signaling 2023 ·Biological Research ·Xiaojun Zhang, Changsen Wang, Hao Xu, Shuyun Cai, Keyu Liu, (unknown), (unknown), (unknown), Xiaoxia Gu, Jing Tang, Zhengyuan Xia, Zhe Hu, Xiaotang Ma, (unknown)	2
6	Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming 2022 ·Journal of Molecular Medicine ·Yueying Yang, Mengzhu Zheng, Fei Han, Lei Shang, Mingxue Li, Xiaoxia Gu, Hua Li, Lixia Chen	12
7	The development of New Delhi metallo-β-lactamase-1 inhibitors since 2018 2022 ·Microbiological Research ·Xiaoxia Gu, Mengzhu Zheng, Lixia Chen, Hua Li	14
8	Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP 2021 ·Journal of Medicinal Chemistry ·Mengzhu Zheng, (unknown), Xiaoxia Gu, Yali Wang, Canrong Wu, Qingzhe Zhang, Wancong Wang, Yang Liu, Yu Liu, (unknown), Lixia Chen, Yirong Zhou, Hua Li	145
9	Furin: A Potential Therapeutic Target for COVID-19 2020 ·iScience ·Canrong Wu, Mengzhu Zheng, Yueying Yang, Xiaoxia Gu, Kaiyin Yang, (unknown), Yang Liu, Qingzhe Zhang, Peng Zhang, Yali Wang, Qiqi Wang, Yang Xu, Yirong Zhou, Yonghui Zhang, Lixia Chen, Hua Li	141
10	Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy 2020 ·Current Medical Science ·(unknown), Mingxue Li, Chen Li, Xiaoxia Gu, Mengzhu Zheng, Lixia Chen, Hua Li	7
11	Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma 2020 ·Journal of Hematology & Oncology ·Kecheng Lei, Xiaoxia Gu, Alvaro G. Alvarado, Yuhong Du, Shilin Luo, Eun Hee Ahn, Seong Su Kang, Bing Ji, Xia Liu, Hui Mao, Haian Fu, Harley I. Kornblum, Lingjing Jin, Hua Li, Keqiang Ye	42
12	The clinical effect of dexmedetomidine combined with parecoxib sodium on sedation, antianxiety and prevention of intubation stress in patients undergoing functional endoscopic sinus surgery: a randomised controlled trial 2020 ·BMC Anesthesiology ·Xiaoxia Gu, (unknown), Jinxian Chen, Jingjing Wang, (unknown), Liangqing Zhang	10
13	Propofol-induced MiR-20b expression initiates endogenous cellular signal changes mitigating hypoxia/re-oxygenation-induced endothelial autophagy in vitro 2020 ·Cell Death and Disease ·Yue Lu, Sijie Wang, Shuyun Cai, Xiaoxia Gu, Jingjing Wang, Yue Yang, Zhe Hu, Xi-He Zhang, (unknown), (unknown), (unknown), Daqing Ma, Liangqing Zhang	18
14	Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH 2019 ·Food & Function ·Mengzhu Zheng, Jing Guo, (unknown), Kaiyin Yang, (unknown), Xiaoxia Gu, Hua Li, Lixia Chen	38
15	Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase 2019 ·Bioorganic Chemistry ·Jing Guo, Xiaoxia Gu, Mengzhu Zheng, Yonghui Zhang, Lixia Chen, Hua Li	31
16	c-Maf inducing protein inhibits cofilin-1 activity and alters podocyte cytoskeleton organization 2017 ·Molecular Medicine Reports ·Lixia Yu, Jianming Ye, Qifeng Liu, Jianhua Feng, Xiaoxia Gu, (unknown), (unknown)	8
17	Klotho mitigates cyclosporine A (CsA)-induced epithelial–mesenchymal transition (EMT) and renal fibrosis in rats 2016 ·International Urology and Nephrology ·Qifeng Liu, Jianming Ye, Lixia Yu, Xiaohong Dong, (unknown), Yan Xiong, Xiaoxia Gu, Shasha Li	33
18	Ginsenoside-Rg1 inhibits endoplasmic reticulum stress-induced apoptosis after unilateral ureteral obstruction in rats 2015 ·Renal Failure ·Shasha Li, (unknown), Zhiyong Deng, Lixia Yu, Xiaoxia Gu, Qifeng Liu	21
19	Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage 2014 ·Cellular Signalling ·Lixia Yu, Yanbo Liu, Yanfeng Wu, Qifeng Liu, Jianhua Feng, Xiaoxia Gu, Yan Xiong, Qingfeng Fan, Jianming Ye	29
20	Ischemic postconditioning downregulates Egr-1 expression and attenuates postischemic pulmonary inflammatory cytokine release and tissue injury in rats 2012 ·Journal of Surgical Research ·(unknown), Shaoqing Lei, Yuan Jiang, Xin Liu, Dayong Zhang, Xiaoxia Gu, Liangqing Zhang, Zhengyuan Xia	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact